Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
77.7M
-
Shares change
-
-25.7M
-
Total reported value, excl. options
-
$97.9M
-
Value change
-
-$40.3M
-
Put/Call ratio
-
2.26
-
Number of buys
-
51
-
Number of sells
-
-71
-
Price
-
$1.26
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q1 2023
147 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q1 2023.
Gossamer Bio, Inc. - Common Stock (GOSS) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.7M shares
of 227M outstanding shares and own 34.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.55M shares), MILLENNIUM MANAGEMENT LLC (5.46M shares), HHLR ADVISORS, LTD. (4.97M shares), BlackRock Inc. (4.79M shares), NEA Management Company, LLC (3.47M shares), Palo Alto Investors LP (3.47M shares), Boxer Capital, LLC (3.34M shares), Artal Group S.A. (3.03M shares), CITADEL ADVISORS LLC (2.79M shares), and PLATINUM INVESTMENT MANAGEMENT LTD (2.36M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.